HomeNASDAQ:AMGN

NASDAQ:AMGN

Amgen Stock’s Strong Performance: What’s Behind It?

Amgen Stock’s Strong Performance: What’s Behind It?

April 3, 2024

FDA Issues CRL for Amgen’s Lumakras NDA Seeking Full Approval

FDA Issues CRL for Amgen’s Lumakras NDA Seeking Full Approval

December 27, 2023

Amgen Stock Gains Nearly 5% on Positive Broker Upgrade

Amgen Stock Gains Nearly 5% on Positive Broker Upgrade

October 12, 2023